Introduction
The creation of functional tissue constructs and other therapeutic products in tissue engineering and regenerative medicine is a highly challenging task. Adequate vascularization of tissueengineered constructs is an important prerequisite and could be promoted by inducing stem cells or progenitor cells to reach the site of injury/replacement for tissue repair (Lapidot et al., 2005; Pelosi et al., 2002) . The development of new approaches leading to fast and successful vascularization is therefore one of the most intensively studied subjects in the field of tissue engineering and regenerative medicine (Moon and West, 2008; Cenni et al., 2011) . Our previous studies demonstrated that endothelial progenitor cells from human peripheral blood or cord blood are a potential autologous cell source for cellular therapies aimed at enhancing the neovascularization of tissue-engineered constructs (Fuchs et al., 2010; Ghanaati et al., 2011; Kolbe et al., 2011; Dohle et al., 2011) . However, in these in vitro angiogenesis studies the effect of one important system present in vivo, namely the immune system, has not been taken into account.
The mammalian immune system consists of two integrated components, the innate and the adaptive systems, whose principal functions are to defend the host against infection by various pathogens (Beutler, 2004) . Recently, it has been shown that the innate immune system also plays an important role in tissue engineering and regenerative medicine (Sefton et al., 2008) . Following biomaterial implantation, host reactions can include tissue injury, blood-material interactions, provisional matrix formation, acute and chronic inflammation, granulation-tissue development, foreign-body reaction, and fibrosis/fibrous capsule development (Morais et al., 2010) . Several studies have recently linked innate immunity to biomaterial implantation (Schmidt et al., 2010; Nilsson et al., 2010) and angiogenesis/vascularization (Frantz et al., 2005) under a variety of pathological conditions.
Innate immune recognition relies on a diverse set of germ-line-encoded receptors, termed pattern recognition receptors (PRR), which bind broad classes of molecular structures common to groups of microorganisms (Takeuchi and Akira 2010) . Toll-like receptors (TLRs), which are related to the Toll protein of Drosophila, are one of the largest and best-studied families of PRR (Akira and Takeda, 2004) . Following the recognition of pathogen-associated molecular patterns (PAMP) of microbial origin, the TLRs alert the immune system and initiate innate and adaptive immune responses (Akira and Takeda, 2004) . However, the TLR system is not confined solely to leukocyte-mediated immune defense against exogenous pathogens. In addition to myeloid cells, TLR expression has been reported in many tissue and cell types (Cho et al., 2007; Kikuchi et al., 2001; Edelman et al., 2007; Zimmer et al., 2011) . Moreover, despite the microbial patterns that are commonly accepted as TLR ligands, increasing evidence indicates that TLRs also recognize host-derived molecules (Yu et al., 2010) .
Recent studies have demonstrated that TLR activation promotes angiogenesis in various inflammatory settings in response to both exogenous and endogenous ligands, although the precise mode of action of TLRs in this context remains ambiguous (Cho et al., 2007; Grote et al., 2010; Varoga et al., 2006; West et al., 2010; Kanzler et al., 2007) . In our previous work, we demonstrated that the coculture of human outgrowth endothelial cells (OECs) isolated from the mononuclear cell fraction of peripheral blood with primary human osteoblasts (pOBs) results in the formation of perfused vascular structures in vitro and in vivo (Fuchs et al., 2010; Ghanaati et al., 2011; Dohle et al., 2011) . Since TLRs are expressed on a variety of cells, including fibroblasts (Cho et al., 2007) , osteoblasts (Kikuchi et al., 2001) , pericytes (Edelman et al., 2007) , and endothelial cells (Zimmer et al., 2011) , an investigation of the role of TLR signaling in angiogenesis/vascularization is of great interest in the context of tissue engineering and biomaterial implantation. The activation or blockade of TLR signaling pathways, using techniques that have been applied in therapeutic approaches for some diseases (Kanzler et al., 2007) , might also be used to promote angiogenesis/vascularization. Among the TLRs we focussed on TLR4, whose activation has been reported to play a role in angiogenesis (He et al., 2013; Jagavelu et al., 2010) . The goal of this study was to investigate the mechanisms by which TLR4 signaling pathways affect angiogenesis and tissue regeneration in a coculture system of OECs and pOBs and to develop potential approaches to promote the vascularization of tissue constructs for applications in tissue engineering and regenerative medicine.
Materials and methods

OEC and pOB cultures
Mononuclear cells were isolated from human peripheral blood buffy coats by Ficoll/histopaque (Sigma-Aldrich, Seelze, Germany) density gradient centrifugations. OECs were then prepared from these mononuclear cells and characterized as previously described (Herzog et al., 2014) .
pOBs were isolated from human bone fragments from healthy donors according to an established protocol approved by the responsible Ethical Commission (Herzog et al., 2014) . pOBs of passage 2 to 5 from several donors and OECs of passage 8 to 18 from 3 donors were used for the study.
For stimulation experiments, OECs or pOBs seeded on 13 mm, rat tail collagen type-I (BD Biosciences, Heidelberg, Germany)-coated glass coverslips (Gerhard Menzel, Braunschweig, Germany) in 24-well culture plates were exposed to 1.25 µg/ml (equal to 1.25x10 3 EU/ml in data sheet) Ultrapure LPS E. coli 0111:B4 (abbreviated as LPS-EB; InvivoGen, Toulouse, France) for 24 hours and processed for further analysis. This preparation of LPS only activates TLR4 when being applied at the concentration range used in this study (Gutschow et al., 2013 OECs/well were added, and the cells were co-cultivated for 7 days or longer in Endothelial Cell
Growth Media (EGM)-2 with 5% FCS, 1% pen/strep, and supplements from kits (EGM-2
BulletKit, Lonza, Basel, Switzerland) before stimulation.
LPS treatment of cocultures of pOBs and OECs
After 7 days of in vitro (DIV7) cocultivation (or longer as described elsewhere), cocultures of OECs and pOBs were exposed to LPS-EB at the described concentrations for 24 hours or longer if needed. After a change of medium, the cocultures were then processed for gene expression analysis and protein/factor analysis. For immunofluorescent staining of microvessels with anti-CD31, the coculture was cultivated for an additional 3 days.
Wound scratch assay
The tip of a yellow Gilson pipette was used to wound the DIV7 OECs on glass coverslips, creating linear defects in the cell layer of about 1 mm breadth. The cells were washed with phosphate-buffered saline (PBS) to remove floating cellular debris and re-fed for an additional 24 hours with EGM medium with and without LPS-EB (1.25µg/ml). After 24 hours, "wound closure" in vitro was photographed by using an inverted microscope (20x, Leica DMI 6000B, Leica Microsystems, Wetzlar, Germany) equipped with a digital camera (Leica DFC 350FX).
Fibrin Gel in vitro Angiogenesis Assay
The Fibrin Gel in vitro Angiogenesis Assay Kit was purchased from CHEMICON (Limburg, Germany). The assay was performed according to the manufacturer's instructions and recommended volumes of reagents and media were used for 24-well plates: (a) 200 μl fibrinogen solution/well was dispensed in wells of a 24-well plate, and after gentle shaking, 133 μl thrombin/well were added, and the plates incubated at 37 ºC for 15 minutes to initiate fibrin polymerization; (b) 5x10 4 OECs in 1 ml EGM medium/well were then added to the fibrin gel; (c) after overnight incubation at 37ºC, the medium was removed from the culture, and the steps in (a)
were repeated to create an additional fibrin layer on top of the cells, following which 1 ml EGM medium with and without 1.25 μg/ml LPS-EB was added to each well, and the plate was placed back into the 37 ºC incubator; (d) after 24 hours, images were photographed by using an inverted microscope (20x, Leica DMI 6000B) equipped with a digital camera (Leica DFC 350FX).
Antibodies
Mouse anti-human CD31 (platelet endothelial cell adhesion molecule (PECAM-1)) and mouse anti-Ki67 protein were purchased from DAKO (Hamburg, Germany). Rabbit anti-human TLR4 was purchased from Antibody Online (Aachen, Germany). Rabbit anti-myeloid differentiation primary response gene 88 (MYD88) was obtained from Pierce Antibodies (Rockford, IL, USA).
Mouse anti-human vascular endothelial growth factor (VEGF) was obtained from Santa Cruz Biotechnology (Heidelberg, Germany). Goat anti-angiopoietin 1, goat anti-angiopoietin 2, and mouse anti-osteocalcin were purchased from R&D systems (Wiesbaden, Germany). Mouse antiosteonectin was obtained from GenWay Biotech (San Diego, CA, USA).
Alexa Fluor® 546-conjugated goat anti-mouse IgG, Alexa Fluor® 546-conjugated goat antirabbit IgG, and Alexa Fluor® 594-conjugated donkey anti-goat IgG were purchased from Life Technologies (Darmstadt, Germany).
Immunofluorescent staining
All dilutions and washes (3×5 minutes) between stages were performed in PBS. Cells or cocultures on 13 mm glass coverslips were fixed with 4% paraformaldehyde ( 
Fluorescence microscopy
Fluorescent imaging was performed by using a Keyence BZ-9000 fluorescence microscope (20x, Keyence, Neu-Isenburg, Germany). Images were acquired and saved in TIFF format. For each experiment, all images were acquired and processed by using the same scales and parameters.
Analysis of microvessel area
ImageJ (version 1.45s) was downloaded from the website (http://rsb.info.nih.gov/ij/) of the National Institutes of Health (Bethesda, MD, USA). All images in one experiment group were processed and analyzed by using the same scales and parameters. (a) Images from fluorescent microscopy were changed to gray-scale and printed on DIN (the German Institute for Standardization) A4 paper (this print-out is named P1); (b) carbon paper for typewriting (CPT, Pelikan, Hannover, Germany) was put underneath P1, and blank A4 white paper was subsequently placed under the CPT; (c) vessels were traced manually by drawing their outlines on P1, and the outlines of vessels were "copied" onto blank A4 paper (this paper is named P2) by CPT; (d) the vessel contours on P2 were then filled with magenta color by using a magenta color marker, P2 was subsequently scanned by using an HP Officejet Pro 8500 A910 Color Scanner (Hewlett-Packard, Böblingen, Germany), and scanned images were saved as TIFF files; (e) images were imported into ImageJ, and the vessels were segmented by using the "Color threshold" function in the "Adjust" submenu of " Image" menu; (f) the vessel area was measured by using the "Analyze particles" function in the "Analyze" menu. Small objects such as dirt particles on the paper were filtered by setting the particle size to be analyzed. Only objects larger than 500 square-pixels were selected for analysis. Parameters of vessels were imported into MSExcel (Microsoft Office; Microsoft) for further analysis. Steps in (e) and (f) were performed in a batch mode in ImageJ.
Analysis of the intensity index
The analysis was performed with ImageJ. All images in one experiment group were processed and analyzed by using the same scales and parameters. Actin staining by Alexa Fluor®488
Phalloidin was used as normalization factor reflecting the biomass of cells in defined areas of monocultures of OECs or pOBs. The intensity index was calculated by using the equation:
Intensity Index = Intensity of target staining/Intensity of actin staining x100. For each experiment, three images from each culture were acquired and analyzed. Parameters obtained from ImageJ were imported into MS-Excel for further analysis.
Enzyme-linked immunosorbent assay (ELISA)
The supernatant of DIV7 cocultures of OECs and pOBs were used for the analysis. ELISA was carried out according to the manufacturer's recommendations (R&D Systems) as previously described (Li et al., 2013) . Reagents for intercellular adhesion molecule 1 (ICAM-1; CD54), Eselectin, interleukin-6 (IL-6), and IL-8 for the ELISA DuoSets® kits were purchased from R&D Systems.
Quantitative real-time polymerase chain reaction (qRT-PCR)
qRT-PCR was performed as previously described (Li et al., 2013) . The sequences for qRT-PCR primers were as follows: VEGF forward 5' CGA GGG CCT GGA GTG TGT 3'; VEGF reverse 5'
CCG CAT AAT CTG CAT GGT GAT 3'; PDGF-BB forward 5' GAT CCG CTC CTT TGA TGA TCT 3'; PDGF-BB reverse 5' TCC AAC TCG GCC CCA TCT 3'. These primers and primers for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) were provided by Qiagen (Hilden, Germany).
Statistical analysis
MS-Excel was used for statistical analysis. Statistically significant differences were evaluated by using the paired Student's t-test (p-value *p<0.05 and **p<0.01). Data are expressed as mean +standard derivation (SD).
Results
LPS-EB stimulation enhances the formation of capillary-like structures in coculture system of pOBs and OECs
To investigate the effects of TLR4 signaling on the formation of capillary-like structures in the cultures, we used a specific type of LPS-EB. This ultrapure LPS, which is extracted by successive enzymatic hydrolysis steps and purified by the phenol-triethylamine-deoxycholate sodium (TEA-DOC) extraction protocol, only activates the TLR4 pathway and is therefore highly suitable for our study. DIV7 cocultures of pOBs and OECs were treated with 1.25 µ/ml LPS-EB for 24 hours, cultivated for an additional 3 day period, and stained for the endothelial marker CD31. Quantitative fluorescence microscopy has been used more and more widely in the analysis of proteins and genes in biological samples and in this study we used it for the quantitative analysis of vessel area and other factors. We observed that the LPS-EB treatment enhanced the formation of capillary-like structures in cocultures of pOBs and OECs significantly ( Figure 1A ). To check whether this effect was concentration-dependent, cocultures were treated with various concentrations of LPS-EB; the results are shown in Figure 1B -C. In all treated cocultures, significant enhancement of microvessel formation was seen when compared with corresponding control cocultures.
We next checked the effect of longer LPS-EB treatment on angiogenesis in the coculture system. DIV7 cocultures of pOBs and OECs were treated with 1.25 µg/ml LPS-EB for 96 hours and cultivated for an additional 3 days prior to CD31 staining. The results are shown in Figure 1D .
Significant enhancement of microvessel formation was seen compared with control cocultures.
However, the stimulation effect was not as strong as that observed in the 24-hour treatment groups ( Figure 1A-C) .
LPS-EB treatment has positive effects on OEC activities related to angiogenesis
To study the mechanism by which TLR4 stimulation enhanced microvessel formation, we investigated first the effect of LPS-EB stimulation on the monocultures of OECs. Typical results of TLR4 staining of DIV7 OECs are shown in Figure 2A . All OECs expressed the endothelial cell marker CD31, and TLR4 staining was observed on the cell membrane and in the cytoplasm of OECs. Expression of TLR4 was observed at other DIV stages of the cultures (data not shown).
After a 24-hour treatment with 1.25 µg/ml LPS-EB, the expression level of TLR4 on OECs increased significantly ( Figure 2B ). In addition, MYD88, an adapter protein that activates the transcription factor, nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB) in TLR4 signaling, was also upregulated in OECs ( Figure 2B ).
Several positive effects on OEC activities related to angiogenesis were also observed. First, LPS-EB treatment enhanced OEC proliferation, which was demonstrated by comparing Ki67 staining in OEC monocultures without and with LPS-EB treatment ( Figure 2C ). Second, the wound scratch assay revealed that the LPS-EB treatment also enhanced the directed cell migration of OECs ( Figure 2D ). Third, LPS-EB treatment on OEC also affected the cell biology related to angiogenesis. The Fibrin Gel in vitro Angiogenesis Assay was applied to evaluate this effect. The results are shown in Figure 3A . After a 24-hour treatment with 1.25 µg/ml LPS-EB, tube formation was observed in OECs of LPS-EB-treated groups, whereas the control group exhibited no obvious tube formation. Fourth, LPS-EB treatment also upregulated significantly the expression levels of VEGF and another two important angiogenic factors, namely angiopoietin 1 and angiopoietin 2, in OEC monocultures ( Figure 3B and Supplementary Figure 1) .
Reorganization of actin filaments is also an important process during angiogenesis (Lamalice et al., 2007) . In this study, we observed that the TLR4 ligand LPS-EB also altered the organization of actin filaments in OECs. The results are shown in Figure 4A -B. Various manifestations of reorganization of actin filaments, such as peripheral accumulation, stress fiber formation, knotted form staining, spike and filopodia formation, as well as F-actin depolymerization in certain areas were observed in OECs after LPS-EB treatment.
LPS-EB treatment upregulates TLR4 and osteogenic markers in pOBs
Typical staining results of TLR4 on DIV5 pOBs are shown in Figure 5A and Supplementary   Figure 2 . TLR4 staining was observed on the cell membrane and in the cytoplasm of pOBs.
Expression of TLR4 on pOBs was also observed at other DIV stages of the cultures (data not shown). After a 24-hour treatment with 1.25 µg/ml LPS-EB, the expression levels of TLR4 and MYD88 increased significantly ( Figure 5B ). We also observed that LPS-EB treatment enhanced OEC proliferation, which was demonstrated by comparing Ki67 staining in pOB monocultures without and with LPS-EB treatment ( Figure 5C ). To study the effect of LPS-EB treatment on osteogenesis, pOBs were treated with 1.25 µg/ml LPS for 24 hours and stained for two important osteogenic factors, namely osteocalcin and osteonectin. The results are shown in Figure 5D . The expression levels of osteocalcin and osteonectin increased significantly after LPS-EB treatment.
LPS-EB treatment upregulates inflammatory and angiogenic factors in cocultures
To analyze the molecular mechanisms leading to angiogenic and osteogenic activation via the LPS-EB treatment of the cocultures, several structural components and inflammatory factors related to the process of angiogenesis were analyzed. The supernatant of DIV7 cocultures of OECs and pOBs were used for ELISA and the results are shown in Figure 6A . We observed that the expression levels of ICAM-1 and E-selectin, which induced angiogenesis and supported the survival of microvessels, increased significantly after 24 hours of LPS-EB treatment. In addition, the expression levels of two cytokines, namely IL-6 and IL-8, which play important roles in endothelial cell survival and exert pro-angiogenic effects on endothelial cells, were also upregulated significantly after 24 hours of LPS-EB treatment. In addition, by using qRT-PCR, we found that the levels of VEGF and PDGF-BB in the cells of cocultures were upregulated after 24 hours of LPS treatment ( Figure 6B ).
Discussion
TLR4 activation and LPS stimulation of endothelial cells have recently been reported to promote angiogenesis in a variety of settings (Jagavelu et al., 2010; Pollet et al., 2003) . In this study, we have demonstrated that TLR4 activation in response to the exogenous TLR4 ligand LPS-EB promotes angiogenesis in a coculture system consisting of OECs and pOBs. Since this LPS-EB preparation only activates TLR4, our data further support the concept in which TLR4 activation by both exogenous and endogenous ligands alters endothelial cell function and promotes angiogenesis. In addition, the precise modes of TLR4 action on the process of angiogenesis have been investigated by using the cocultures and monocultures of OEC/pOB, separately.
TLR4 signaling in the OECs
Recently, it has been shown that not only macrophages, but also resident smooth muscle and endothelial cells, contribute to vascular inflammation and dysfunction (Edelman et al., 2007; Zimmer et al., 2011; Hickey and Kubes, 2009) . In the present study we show that OECs are immune-competent cells that can actively participate in innate immunity. All CD31 + cells express TLR4, and the staining patterns are similar to those of some previously reported studies (Jagavelu et al., 2010; Kang et al., 2009) . LPS-EB stimulation of TLR4 significantly upregulates the expression of TLR4 and its adapter protein MYD88 on OECs. Although OECs are negative for CD14 (Medina et al., 2010) , a co-receptor for LPS, the TLR4 signalling can be initiated through a MYD88-dependent pathway instead of the TLR4/TRAM-TRIF pathway (MYD88-independent, CD14 is needed; Jiang et al., 2005) . This stimulatory effect has been observed by using various concentrations of LPS-EB (from ng/ml to µg/ml, latter data not shown). Immunostaining and the wound scratch assay also demonstrated that this stimulation improves OEC proliferation and directional migration, two important steps in angiogenesis/vasculogenesis.
VEGF (a subfamily of PDGF) and the angiopoietins (members of a family of vascular growth factors) cooperatively orchestrate the individual steps during new vessel formation and stabilization in development and repair (Asahara et al., 1998) . VEGF can induce pro-angiogenic activation of endothelial cells, and this activation is facilitated by angiopoietin-2, leading to the destabilization of cell-cell and cell-matrix interactions in endothelial cells. These steps are crucial in the angiogenesis process (Asahara et al., 1998) . It also has been reported that angiopoietin-2 promotes angiogenesis through integrin signaling instead of TIE2 signaling (Felcht et al., 2012) . In addition, the stabilization of the vessels can be promoted by angiopoietin-1 through the recruitment of other resident cells such as smooth muscle cells (Suri et al., 1998) . In this study, several findings are related to the angiogenesis potential of OECs. First, after LPS-EB stimulation, the amount of VEGF in OECs increases significantly. Second, the expression level of angiopoietin-1 increases after LPS-EB regulation. Third, the OECs also expressed angiopoietin-2, and its level is significantly upregulated after LPS-EB treatment. Fourth, LPS-EB stimulation has effects on OECs and their actin filament reorganization, which is also an important process in angiogenesis (Lamalice et al., 2007) . All these findings demonstrate that TLR4 activation through LPS-EB at the designated concentrations can improve the angiogenic potential/capabilities of OECs.
TLR4 signaling in the pOBs
Recent studies have suggested that osteoblasts are also immune competent and can actively participate in innate immunity (Stanley et al., 2006) . Bone cells are now known to express TLRs (Kikuchi et al., 2001; Stanley et al., 2006) . In the present study, pOBs expressed TLR4, and the expression level was upregulated after LPS-EB treatment. This stimulation effect was observed by using various concentrations of LPS-EB (from ng/ml to µg/ml, latter data not shown). In addition, immunostaining demonstrated that this stimulation also improves the proliferation of pOBs, another important step in osteogenesis. Furthermore, two crucial osteogenesis markers, namely osteocalcin and osteonectin, are upregulated after a 24-hour LPS-EB treatment. All these findings demonstrate that TLR4 activation through LPS-EB at the designated concentrations enhances the osteogenic capabilities of pOBs. These data are at variance with results indicating that LPS stimulation inhibits mouse osteogenesis under inflammatory conditions (Tomomatsu et al., 2009 ).
TLR4 signaling in cocultures
Pre-vascularization strategies based on the inclusion of endothelial cells in tissue constructs utilizes the natural interaction of endothelial cells with angiogenic factor-producing cells, either present or recruited to the regenerative niche. Several studies have previously reported that these pre-vascularization strategies might also be applied to promote vascularization in bone tissue engineering. A coculture system consisting, for example, of pOBs and OECs supports the formation of vascular structures in vitro and their inosculation following implantation in vivo (Fuchs et al., 2009) . In this study we have observed that LPS treatment enhances the formation of microvessels in cocultures of pOBs and OECs. The pathways that lead to this enhancement of microvessels have also been investigated.
First, the levels of ICAM-1 and E-selectin, which can promote angiogenesis and support the survival of microvessels (Oh et al., 2007; Wu et al., 2006) increased significantly after 24 hours of LPS treatment. Second, LPS-EB treatment enhanced the expression of some cytokines in the cocultures, such as IL-6 and IL-8, as shown by the protein arrays data. IL-6 is involved in angiogenesis by controlling the levels of VEGF (Hernández-Rodríguez et al., 2003; Middleton et al., 2014) . IL-8 is known to play an important role in endothelial cell survival (Li et al., 2003) and exerts pro-angiogenic effects on endothelial cells (Heidemann et al., 2003) . It has been reported that all these three factors (IL-6, IL-8 and VEGF) are expressed on human endothelial cells and osteoblasts (Lee et al., 2014) . Third, the level of VEGF and PDGF-BB mRNAs were also upregulated after LPS treatment. In our study, we observed that VEGF is expressed in pOB monocultures by using immunocytochemistry. Furthermore, the level of VEGF in pOBs The first involves infection and other conditions involving LPS in the human body (e.g., in the gut) in which exogenous TLR4 ligand activates the TLR4 pathway. The second involves sterile inflammatory conditions in which TLR4 can be activated by endogenous TLR ligands (Taylor et al., 2007; Schaefer et al., 2005; Smiley et al., 2001; Okamura et al., 2001) . The third involves biomaterial applications, as some biomaterials have been shown to activate TLR4 pathways (Shokouhi et al., 2010; Islam et al., 2011) .
Coculture techniques in combination with additional intervention through TLR signaling represent a promising approach with respect to the formation of a stable vasculature and osteogenic differentiation in bone engineering. New approaches simultaneously enhancing the two fundamental processes in bone regeneration, namely, osteogenesis and angiogenesis could be of considerable therapeutic potential. According to this study, LPS and its agonists might improve both processes and therefore could be used for intervention in angiogenesis in vivo.
Synthetic TLR4 agonists such as glucopyranosyl lipid adjuvant (GLA; Arias et al., 2012) or synthetic TLR-4 agonist peptides (Shanmugam et al., 2012) , which could activate the TLR4
signaling, should therefore be tested for their potential applications in promoting angiogenesis/vasculogenesis in tissue constructs in tissue engineering and regenerative medicine. µg/ml LPS-EB for 24 hours and stained for TLR4, MYD88, Ki67, and osteogenic markers, namely osteocalcin and osteonectin. The quantitation of the staining is shown in the panels on the right. For each experiment, three images from cocultures were acquired and analyzed.
Significance of difference was assessed by the p-value (**p < 0.01). Scale bars: 50 µm. 
